SIGMA Pharmaceuticals is
reportedly facing possible legal
action over its $297m capital
raising last year and subsequent
writedown of the goodwill value of
its generics business.
A spokesperson for US-based
Comprehensive Legal Funding has
confirmed an approach by
institutional investors in Australia
over the company’s extended
trading halt, according to The Age.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Apr 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Apr 10
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.